文献速递认知障碍与痴呆神经肌肉病

大Tau亚型在人中枢与外周神经系统中的分布

Distribution of Big Tau Isoforms in the Human Central and Peripheral Nervous System.
PubMed 文献 · Ann Neurol · 2026-07-19

研究通过质谱法刻画大Tau(big tau)的组成、解剖分布及疾病相关性。大Tau由外显子4a插入355或251个氨基酸形成,在外周神经占总Tau的50%,在脑内仅约1%且主要位于小脑。脑脊液中大Tau水平不受淀粉样蛋白异常或认知障碍影响,而经典Tau随AD病理升高。

要点

  • 大Tau由外显子4a-long(355氨基酸)或4a-short(251氨基酸)插入产生。
  • 大Tau在外周神经占总Tau的50%,在脑内仅约1%且主要位于小脑。
  • 脑脊液大Tau不受淀粉样蛋白异常或认知障碍影响,经典Tau随AD病理升高。

核心结论

  • 大Tau是富集于外周神经系统的独立Tau群体,与脑源性Tau的疾病相关变化无关。
  • 区分大Tau与经典Tau可能改善Tau生物标志物解读,并有助于鉴别中枢神经变性与周围神经病变。

研究设计与样本

  • 采用质谱法测序大Tau并绘制其在人神经系统中的分布。
  • 死后样本包括AD、ALS和对照的脑组织,以及脊髓和周围神经。
  • 在对照及按淀粉样蛋白状态和认知障碍分层的受试者脑脊液中定量大Tau与经典Tau。

主要发现

  • 人大Tau由外显子4a-long编码355个氨基酸或外显子4a-short编码251个氨基酸插入形成。
  • 外显子2、3和10的可变剪接产生多种大Tau亚型。
  • 脑内总Tau水平约为外周神经的1,000倍,但大Tau相对丰度从CNS到PNS升高。
  • 大Tau占外周总Tau的50%,占脑内总Tau约1%且主要定位于小脑。
  • 脑脊液大Tau水平不随淀粉样蛋白异常或认知障碍改变,而经典Tau随AD病理升高。

临床怎么用

  • 解读Tau生物标志物时应考虑大Tau与外周神经来源的贡献。
  • 大Tau可能有助于区分中枢神经变性与周围神经病理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tau is widely studied in neurodegeneration, yet most work has focused on canonical brain tau isoforms. A longer isoform, "big tau," produced by inclusion of exon 4a, is expressed in the peripheral nervous system (PNS) and central nervous system (CNS) regions. We sought to characterize big tau composition, anatomic distribution, and disease relevance. METHODS: Mass spectrometry (MS) was used to sequence big tau and map its distribution across the human nervous system. Postmortem samples included brain tissue from Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and controls; spinal cord and peripheral nerves. Big and canonical ("small") tau isoforms were also quantified in cerebrospinal fluid (CSF) from controls and participants stratified by amyloid status and cognitive impairment. RESULTS: Human big tau results from insertion of either 355 or 251 amino acids encoded by exon 4a-long and exon 4a-short, respectively. Alternative splicing of exons 2, 3, and 10 generates multiple big tau isoforms. Total tau levels were approximately 1,000-fold higher in the brain than in the PNS; however, the relative abundance of big tau increased from the CNS to the PNS, comprising 50% of the total tau in the periphery and approximately 1% in the brain, primarily localized to the cerebellum. In CSF, big tau levels were unchanged by amyloid abnormalities or cognitive impairment, whereas canonical tau increased with AD pathology. INTERPRETATION: Big tau represents a distinct tau population enriched in the PNS and uncoupled from disease-associated changes in brain-derived tau, suggesting that distinguishing big tau from canonical tau may improve interpretation of tau biomarkers and help differentiate CNS neurodegeneration from peripheral nerve pathology. ANN NEUROL 2026;100:709-736.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Koppisetti RK, Barthélemy NR, Horie K, et al. Distribution of Big Tau Isoforms in the Human Central and Peripheral Nervous System. Ann Neurol. 2026. PMID: 42473039. doi:10.1002/ana.78300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。